Cedrus LLC Edwards Lifesciences Corp Transaction History

Cedrus LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 24, 2024	SELL	$69.28 - $93.38 $177,980 - $239,893	-2,569 Closed	0 $0
Q1 2023 Jan 24, 2024	SELL	$74.26 - $84.51 $16,708 - $19,014	-225 Reduced 8.05%	2,569 $213 Million
Q4 2022 Jan 19, 2024	SELL	$68.3 - $87.44 $13,386 - $17,138	-196 Reduced 6.56%	2,794 $208 Million
Q3 2022 Jan 19, 2024	SELL	$82.37 - $107.29 $4,777 - $6,222	-58 Reduced 1.9%	2,990 $247 Million
Q2 2022 Jan 19, 2024	BUY	$86.5 - $128.27 $17,213 - $25,525	199 Added 6.98%	3,048 $290 Million
Q1 2022 Jan 19, 2024	SELL	$101.96 - $128.34 $8,054 - $10,138	-79 Reduced 2.7%	2,849 $335 Million
Q4 2021 Jan 19, 2024	BUY	$106.37 - $130.68 $311,451 - $382,631	2,928 New	2,928 $379 Million

1,351

466M

2.45M

2.56M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

Stay updated on Cedrus LLC with notifications on news.